The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 166 participants.

Also called NCT04094038

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 166 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04094038
  • EudraCT 2018-003899-13
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04094038. Randomized; quadruple masking; primary purpose treatment. Start 2019-09-16 (actual); primary completion 2024-04-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
Condition
End Stage Renal Disease
Condition
Malnutrition
Condition
Sarcopenia
Condition
Hemodialysis Complication
Intervention (Drug)
Olimel N12
Intervention (Drug)
Glucose IV
Lead sponsor
Erasmus Medical Center (class: other)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct04094038
Content hash
7c26be499feb32558b96ac1e1cef9dc0663dc9b0b995a451b7610da639ef3b26